Catherine Skari
-
Nov- 2019 -12 NovemberNews
TIF will coordinate efforts for patients’ information on Reblozyl in 62 countries
A new and encouraging chapter is finally opening up for patients with thalassaemia, following the recent approval of the US…
Read More » -
7 NovemberNews
ASH ANNUAL MEETING | 7-10 December 2019
Celgene Corporation, Acceleron Pharma, Sangamo Therapeutics & Agios Pharmaceuticals are expected to present new and updated data on the…
Read More » -
7 NovemberNews
Deferasirox Mylan: A new generic drug for the treatment of iron overload in β-thalassaemia major obtained approval by the EMA
The European Medicines Agency’s (EMA) has recently granted marketing authorisation for the medicinal product ”Deferasirox Mylan”, intended for the treatment of…
Read More » -
4 NovemberEvents
High-Level Thalassaemia & Sickle Cell Disease Healthcare Professionals Summit – 1 & 2 November 2019
After the successful Capacity Building Workshop for Patient Organizations & Patients with thalassaemia, TIF will be traveling to Thessaloniki, Greece…
Read More » -
4 NovemberNews
US government & Gates Foundation pledge $200 million to bring gene therapies to patients with Sickle Cell Disease & HIV
The National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation will each invest $100 million over the next four…
Read More » -
1 NovemberNews
New CRISPR editing tool could potentially fix 89% of genetic variations in human diseases
Scientists have raised fresh hopes for treating people with genetic disorders by inventing a powerful new molecular tool that, in…
Read More » -
Oct- 2019 -26 October
-
22 OctoberNews
As survival increases in β-thalassemia, renal complications emerge
In a scientific paper recently published in Hematology, researchers discussed the most common pathophysiologic and clinical manifestations of renal…
Read More » -
7 OctoberNews
The future of genome editing in Europe – Bringing together the views of government, industry, patient communities, and civil society’ representatives
Genome editing is a breakthrough healthcare technology which has the potential to notably change treatment options, largely influence current…
Read More » -
Sep- 2019 -30 September
